RNS
TECH icon

Robert N. Shapiro’s Bio-Techne TECH Stock Holding History

Robert N. Shapiro’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-800
Closed -$16K – 895
2013
Q3 		$16K Hold
800
– – ﹤0.01% 808
2013
Q2 		$14K Buy
+800
New +$13.3K ﹤0.01% 751

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Robert N. Shapiro's TECH Position: Q4 2013 in Review

Robert N. Shapiro sold out of Bio-Techne (TECH) in Q4 2013, closing a stake of 800 shares — an estimated $16K sold.

Robert N. Shapiro first reported a position in TECH in Q2 2013 and held it in 2 quarters. The position peaked at $16K in Q3 2013. 245 funds tracked by Wall St. Rank hold TECH as of Q4 2013.

  • Robert N. Shapiro reported no remaining Bio-Techne position as of Q4 2013 after selling out during the quarter.
  • Robert N. Shapiro sold 800 Bio-Techne shares in Q4 2013, an estimated $16K.
  • Robert N. Shapiro first reported a position in Bio-Techne in Q2 2013 and held it in 2 quarters.
  • Robert N. Shapiro's Bio-Techne position peaked at $16K in Q3 2013.
  • 245 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2013.

Based on Robert N. Shapiro's 13F filing for Q4 2013, filed 6 Feb 2014.